REDWOOD CITY, CA / ACCESSWIRE / June 5, 2023 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for ...
REDWOOD CITY, CA / ACCESSWIRE / September 18, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based ...
DUBLIN--(BUSINESS WIRE)--The "CTO Device Market | US | Units Sold, Average Selling Prices, Forecasts | 2018-2024| MedCore" report has been added to ResearchAndMarkets.com's offering. The value of the ...
(updated March 25, 2017) Dr Seung-Jung Park from the Asan Medical Center in Seoul South Korea presented the DECISION-CTO trial at the American College of Cardiology (ACC) 2017 Scientific Sessions. [1] ...
This increase in procedural success and patient safety has rendered CTO procedures a more desirable and feasible option for physicians and patients alike, driving doctors to more readily refer ...
Performing PCI on a chronic total occlusion (CTO), or in fact doing any type of transcatheter intervention, is associated with a significant stress response for the interventional cardiologist beyond ...
REDWOOD CITY, CA / ACCESSWIRE / January 9, 2020 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results